These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 2951292)

  • 1. Bile duct strictures associated with hepatic arterial infusion chemotherapy.
    Clark RA; Gallant TE
    Gastrointest Radiol; 1987; 12(2):148-51. PubMed ID: 2951292
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Extrahepatic biliary stenoses after hepatic arterial infusion (HAI) of floxuridine (FUdR) for liver metastases from colorectal cancer.
    Aldrighetti L; Arru M; Ronzoni M; Salvioni M; Villa E; Ferla G
    Hepatogastroenterology; 2001; 48(41):1302-7. PubMed ID: 11677951
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Common duct stricture associated with hepatic artery infusion of FUDR.
    Laughlin EH
    J Surg Oncol; 1986 Jan; 31(1):56-9. PubMed ID: 2935680
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sclerosing cholangitis from intraarterial floxuridine.
    Dikengil A; Siskind BN; Morse SS; Swedlund A; Bober-Sorcinelli KE; Burrell MI
    J Clin Gastroenterol; 1986 Dec; 8(6):690-3. PubMed ID: 2949003
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biliary sclerosis in patients receiving hepatic arterial infusions of floxuridine.
    Hohn D; Melnick J; Stagg R; Altman D; Friedman M; Ignoffo R; Ferrell L; Lewis B
    J Clin Oncol; 1985 Jan; 3(1):98-102. PubMed ID: 3155548
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cholangitis complicating intraarterial chemotherapy in liver metastasis.
    Botet JF; Watson RC; Kemeny N; Daly JM; Yeh S
    Radiology; 1985 Aug; 156(2):335-7. PubMed ID: 3160063
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Sclerosing cholangitis after chemotherapy by continuous hepatic intra-arterial infusion of fluorodeoxyuridine].
    Bergmann JF; Rougier P; Liguory C; Zafrani ES; Métreau JM; Dhumeaux D
    Gastroenterol Clin Biol; 1986 Feb; 10(2):177-9. PubMed ID: 2939001
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chemotherapy-induced sclerosing cholangitis: long-term response to endoscopic therapy.
    Alazmi WM; McHenry L; Watkins JL; Fogel EL; Schmidt S; Sherman S; Lehman GL
    J Clin Gastroenterol; 2006 Apr; 40(4):353-7. PubMed ID: 16633109
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sclerosing cholangitis after continuous hepatic artery infusion of FUDR.
    Kemeny MM; Battifora H; Blayney DW; Cecchi G; Goldberg DA; Leong LA; Margolin KA; Terz JJ
    Ann Surg; 1985 Aug; 202(2):176-81. PubMed ID: 3160313
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endoscopic biliary stent placement for bile duct stricture after hepatic artery infusion of 5-FUDR.
    Siegel JH; Ramsey WH
    J Clin Gastroenterol; 1986 Dec; 8(6):673-6. PubMed ID: 2949002
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Iatrogenic sclerosing cholangitis following hepatic arterial chemotherapy infusion.
    Pien EH; Zeman RK; Benjamin SB; Barth KH; Jaffe MH; Choyke PL; Clark LR; Paushter DM
    Radiology; 1985 Aug; 156(2):329-30. PubMed ID: 3160062
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Complications of hepatic arterial infusion chemotherapy.
    Pozniak MA; Babel SG; Trump DL
    Radiographics; 1991 Jan; 11(1):67-79. PubMed ID: 1825358
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bile duct complications of hepatic arterial infusion chemotherapy evaluated by helical CT.
    Phongkitkarun S; Kobayashi S; Varavithya V; Huang X; Curley SA; Charnsangavej C
    Clin Radiol; 2005 Jun; 60(6):700-9. PubMed ID: 16038698
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatic perfusion with FUdR utilizing an implantable system in patients with liver primary cancer or metastatic cancer confined to the liver.
    Seeger J; Woodcock TM; Blumenreich MS; Richardson JD
    Cancer Invest; 1989; 7(1):1-6. PubMed ID: 2544247
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gastroduodenal ulceration after hepatic arterial infusion chemotherapy.
    Hall DA; Clouse ME; Gramm HF
    AJR Am J Roentgenol; 1981 Jun; 136(6):1216-8. PubMed ID: 6453517
    [No Abstract]   [Full Text] [Related]  

  • 16. Gastric mucosal injury after hepatic arterial infusion chemotherapy with floxuridine. A clinical and pathologic study.
    Doria MI; Doria LK; Faintuch J; Levin B
    Cancer; 1994 Apr; 73(8):2042-7. PubMed ID: 8156508
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biliary sclerosis associated with hepatic artery infusion of floxuridine.
    Bolton JS; Bowen JC
    Surgery; 1986 Jan; 99(1):119-22. PubMed ID: 2934836
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatobiliary scintigraphy in patients receiving hepatic artery infusion chemotherapy.
    Housholder DF; Hynes HE; Dakhil SR; Marymont JV
    J Nucl Med; 1985 May; 26(5):474-7. PubMed ID: 3157786
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sclerosing cholangitis associated with hepatic arterial FUDR chemotherapy: radiographic-histologic correlation.
    Shea WJ; Demas BE; Goldberg HI; Hohn DC; Ferrell LD; Kerlan RK
    AJR Am J Roentgenol; 1986 Apr; 146(4):717-21. PubMed ID: 2937274
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gastrointestinal ulceration and hemorrhage from hepatic arterial infusion chemotherapy.
    Ter RB; Infantolino A; Leite LP; Ahtaridis G
    Gastrointest Endosc; 1999 Jan; 49(1):92. PubMed ID: 9869729
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.